Neurobiological alteration in agitation in Alzheimer's disease and possible interventions

被引:1
|
作者
Rao, Jagadeesh S. [1 ]
Tangarife, Maria Alejandra [1 ]
Mukunda, Ram [1 ]
机构
[1] India Globalizat Capital IGC Pharm, Sci Dept, Potomac, MD 20859 USA
来源
FRONTIERS IN PSYCHIATRY | 2024年 / 15卷
关键词
agitation; Alzheimer's disease; neuroinflammation; GABA; CBR-1; THC; melatonin; SYMPTOMS; DRONABINOL; CORTEX; GABA;
D O I
10.3389/fpsyt.2024.1412901
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
    Rita Khoury
    Neural Regeneration Research, 2022, (05) : 1013 - 1014
  • [22] Developing medicines for agitation and aggression in Alzheimer's disease
    Ames, David
    INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 (02) : 179 - 179
  • [23] The neurochemistry of agitation in Alzheimer's disease: a systematic review
    Liu, Kathy Y.
    Stringer, Aisling E.
    Reeves, Suzanne J.
    Howard, Robert J.
    AGEING RESEARCH REVIEWS, 2018, 43 : 99 - 107
  • [24] Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
    Khoury, Rita
    NEURAL REGENERATION RESEARCH, 2022, 17 (05) : 1013 - 1014
  • [25] Role of citalopram in the treatment of agitation in Alzheimer's disease
    Porsteinsson, Anton P.
    Keltz, Melanie A.
    Smith, Jessica S.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2014, 4 (05) : 345 - 349
  • [26] Prazosin for the Treatment of Disruptive Agitation in Alzheimer's Disease
    Wang, Lucy Y.
    Shofer, Jane B.
    Rohde, Kirsten
    Hart, Kim L.
    Hoff, David J.
    Raskind, Murray A.
    Peskind, Elaine R.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A111 - A111
  • [27] Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease
    Liu, Celina S.
    Chau, Sarah A.
    Ruthirakuhan, Myuri
    Lanctot, Krista L.
    Herrmann, Nathan
    CNS DRUGS, 2015, 29 (08) : 615 - 623
  • [28] Citalopram for agitation in Alzheimer's disease: Design and methods
    Drye, Lea T.
    Ismail, Zahinoor
    Porsteinsson, Anton P.
    Rosenberg, Paul B.
    Weintraub, Daniel
    Marano, Christopher
    Pelton, Gregory
    Frangakis, Constantine
    Rabins, Peter V.
    Munro, Cynthia A.
    Meinert, Curtis L.
    Devanand, D. P.
    Yesavage, Jerome
    Mintzer, Jacobo E.
    Schneider, Lon S.
    Pollock, Bruce G.
    Lyketsos, Constantine G.
    ALZHEIMERS & DEMENTIA, 2012, 8 (02) : 121 - 130
  • [29] Quetiapine in the treatment of agitation in patients with Alzheimer's disease
    Zhong, K
    Tariot, P
    Minkwitz, M
    Devine, N
    Mintzer, J
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 325 - 326
  • [30] Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
    Celina S. Liu
    Sarah A. Chau
    Myuri Ruthirakuhan
    Krista L. Lanctôt
    Nathan Herrmann
    CNS Drugs, 2015, 29 : 615 - 623